Philip J. Vickers
CIK 1635046 · last filed 2026-04-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
3
Total Filings
19
Lifetime Open-Market Net
$138.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AKBA | Director | — | $0.92 | — | $0 | 1 | 2026-04-03 |
| Tectonic Therapeutic, Inc. (AVRO) Delisted | Director | 4,800 | $16.80 | $80.6K | $40.1K | 7 | 2023-06-08 |
| Revance Therapeutics, Inc. (RVNC) Delisted | Director | 29,722 | $3.65 | $108.5K | $98.4K | 11 | 2022-05-13 |
Recent Filings · Page 2 of 2
19 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-06-13 | Tectonic Therapeutic, Inc. (AVRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-10 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +4,500 | $0 | EDGAR |
| 2019-01-09 | Tectonic Therapeutic, Inc. (AVRO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-11 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +3,000 | $0 | EDGAR |
| 2018-03-16 | Revance Therapeutics, Inc. (RVNC) Delisted | Buy (P) | +3,150 | $98.4K | EDGAR |
| 2017-05-12 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +3,000 | $0 | EDGAR |
| 2016-05-09 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-05-15 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-03-02 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–19 of 19
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.